BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

FAGRON NORTH AMERICA — Lobbying — Receipts Report

LD-2 disclosure · Registration - Amendment

FAGRON NORTH AMERICA

via WILLIAMS AND JENSEN, PLLC

1st Quarter (Jan 1 - Mar 31) · 2015Posted Apr 13, 2015Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: FAGRON NORTH AMERICA
Description: Pharmaceuticals
Location: Florida · United States of America

Registrant

Firm: WILLIAMS AND JENSEN, PLLC
Description: Lobbying Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
Issues related to Drug Quality and Security Act (DQSA) and pharmacy compounding.
LobbyistsKARINA LYNCH
Covered position (KARINA LYNCH): Senate Committees on Aging and Gov Affairs

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.